The suicide brain: A review of postmortem receptor/transporter binding studies

Neuroscience and Biobehavioral Reviews

Volumn 22, Issue 5, 1998, Pages 653-661

  Gross Isseroff, Ruth ^a   Biegon, Anat ^b   Voet, Hillary ^c   Weizman, Abraham ^d  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b PHARMOS LTD   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Brain; Depression; GABA; Norepinephrine; Opioids; Serotonin; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ACETYLCHOLINE; ADRENERGIC RECEPTOR; BENZODIAZEPINE; CATECHOLAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; OPIATE; SEROTONIN; SEROTONIN 1D RECEPTOR; SEROTONIN 3 RECEPTOR;

ADRENERGIC SYSTEM; AUTOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; SUICIDAL BEHAVIOR;

EID: 0031744949     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(97)00061-4     Document Type: Article

References (75)

1. 2- and β-adrenergic receptor binding sites in the brain of suicide victims. Arch. Gen. Psychiatry. 47:1990;1038-1047.
2. 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res. 630:1993;271-282.
3. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and post-synaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
4. Arora R.C., Meltzer H.Y. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry. 146:1989;730-736.
5. 3H-Imipramine binding in the frontal cortex of suicides. Psychiatry Res. 30:1989;125-135.
6. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol. Psychiatry. 35:1994;457-463.
7. Biegon A., Israeli M. Regionally selective increases in β-adrenergic receptor density in the brains of suicide victims. Brain Res. 442:1988;199-203y.
8. Biegon A., Earley B., Hanau M., Segal M. Aging and muscarinic receptor subtypes: Autoradiographic analysis in rat and human brain. Abstr. Soc. Neurosci. 14(2):1988;1269.
9. Bronisch T., Hecht G. Comparison of depressed patients with and without suicide attempts in their past history. Acta Psychiatr. Scand. 76:1987;438-449.
10. 2 receptor binding sites in depressed suicide victims. Brain Res. 443:1988;272-280.
11. A/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res. 460:1988;114-123.
12. 1 binding sites in depressed suicides. Psychopharmacology. 102:1990;544-548.
13. Chopin P., Moret C., Briley M. Neuropharmacology of 5-hydroxytriptamine 1B/D receptor ligands. Pharmacol. Ther. 62:1994;385-405.
14. B binding sites in depressed suicide victims. Psychiatry Res. 26:1988;119-129.
15. Crow T.J., Cross A.J., Cooper S.J., Deakin J.F.W., Ferrier I.N., Johnson J.A., Joseph M.H., Owen F., Poulter M., Lofthouse R., Corsellis J.A.N., Chambers D.R., Blessed G., Perry E.K., Perry R.H., Tomlinson B.E. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology. 23:1984;1561-1569.
16. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L.E., Horton R.W. Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res. 525:1990;71-77.
17. De Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L.E., Horton R.W. Brain β-adrenoceptor binding sites in depressed suicide victims: effects of antidepressant treatment. Psychopharmacology. 105:1991;283-288.
18. 2-adrenoceptor binding sites in antidepressant-treated suicides and controls. Br. J. Pharmacol. 104:1991;275P.
19. 1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 554:1991;56-64.
20. Drake R.E., Gates C., Whitaker A., Cotton P.G. Suicide among schizophrenics: A review. Comp. Psychiatry. 26:1985;90-100.
21. Ferrier I.N., McKeith I.G., Cross A.J., Perry E.K., Candy J.M., Perry R.H. Postmortem neurochemical studies in depression. Ann. NY Acad. Sci. 487:1986;128-142.
22. 3]HAMPA binding in postmortem human brain from psychotic subjects and controls: Increases in caudate nucleus associated with suicide. Exp. Neurol. 121:1993;48-56.
23. Gabilondo A.M., Meana J.J., Garcia-Sevilla J.A. Increased density of μ-opioid receptors in the postmortem brain of suicide victims. Brain Res. 682:1995;245-250.
24. Ganel, R. Interactions between the noradrenergic and cholinergic systems in the mammalian brain and their connection to affective disorders. Thesis for the Degree of Master of Science. The Feinberg Graduate School of the Weizmann Institute of Science, Rehovot, Israel, 1990.
25. 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J. Neurochem. 63:1994;256-265.
26. 3H]desmethylimipramine binding in the human brain postmortem. Brain Res. 456:1988;120-126.
27. Gross-Isseroff R., Israeli M., Biegon A. Autoradiographic analysis of tritiated imipramine binding in the humam brain post mortem: effects of suicide. Arch. Gen. Psychiatry. 46:1989;237-241.
28. 1-noradrenergic receptors in the human brain postmortem: effect of suicide. Arch. Gen. Psychiatry. 47:1990;1049-1053.
29. Gross-Isseroff R., Dillon K.A., Israeli M., Biegon A. Regionally selective increases in μ opioid receptor density in the brains of suicide victims. Brain Res. 530:1990;312-316.
30. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res. 507:1990;208-215.
31. Gross-Isseroff, R.; Fieldust, S.J.; Biegon, A. Postmortem autoradiographic analysis of μ opioid receptors in the brains of suicide victims, 1996, submitted.
32. 2-noradrenergic receptors in postmortem brains of suicide victims and controls: an evaluation of age and alcohol effects, 1997, submitted.
33. Gross-Isseroff, R., Fieldust, S.J., Biegon, A. Postmortem autoradiographic analysis of (opioid receptors in the brains of suicide victims, 1997, submitted.
34. 3H]MK-801, in brain samples from drug free depressed suicides. Brain Res. 616:1993;138-143.
35. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 614:1993;37-44.
36. Hubank M., Schatz D.G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:1994;5640-5648.
37. Jain M. Neuropsychobiology of affective disorders. Some methodological considerations. Neuropsychobiology. 2:1976;247-257.
38. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Res. 526:1990;17-22.
39. Lisitsyn N., Lisitsyn N., Wigler M. Cloning the difference between two complex genomes. Science. 259:1993;946-951.
40. Little K.Y., Clark T.B., Ranc J., Duncan G.E. β-Adrenergic receptor binding in frontal cortex from suicide victims. Biol. Psychiatry. 34:1993;596-605.
41. Little K.Y., McLauglin D.P., Ranc J., Gilmore J., Lopez J.F., Watson S.J., Carroll F.I., Butts J.D. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol. Psychiatry. 41:1997;1156-1164.
42. 2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res. 642:1994;281-289.
43. Manchon M., Kopp N., Rouzioux J.J., Lecestre D., Deluermoz S., Miachon S. Benzodiazepine receptor and neurotransmitter studies in the brain of suicides. Life Sci. 41:1987;2623-2630.
44. Mann, J.J. Violence and aggression. In: Bloom, F.E.; Kupfer, D.J. eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:1919-1928.
45. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiatry. 43:1986;954-959.
46. 3 receptor binding kinetics in the cortex of suicide victims are normal. Neural Transm. 103:1996;165-171.
47. 1A binding sites in frontal cortex of suicide victims. Neural Trans. Gen. Sect. 85:1991;181-194.
48. 1-Adrenoceptor binding sites in post-mortem brain samples from antidepressant-free suicides and controls. Proc. Br. Pharmacol. Soc. Southampton 3; 1991.
49. McKeith I.G., Marshall E.F., Ferrier I.N., Armstrong M.M., Kennedy W.N., Perry R.H., Perry E.K., Eccleston D. 5-HT receptor binding in post-mortem brain from patients with affective disorder. J. Affect. Disord. 13:1987;67-74.
50. 2-adrenoceptor density in the frontal cortex of depressed suicide victims. J. Neural Transm. 70:1987;377-381.
51. 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol. Psychiatry. 31:1992;471-490.
52. 3H]idazoxan binding sites in the frontal cortex of depressed suicide victims. Biol. Psychiatry. 34:1993;498-501.
53. Meyerson L.R., Wennogle L.P., Abel M.S., Coupet J., Lippa A.S., Rauh C.E., Beer B. Human brain receptor alterations in suicide victims. Pharmacol. Biochem. Behav. 17:1982;159-163.
54. Molcho, A.; Parson, B.; Kassir, S.; Huang, Y.; Stanley M. Cortical μ opioid receptors in suicide of adolescents and young adults. Abstracts of the Third Meeting of the Isreal Society for Biological Psychiatry, Kfar Giladi, Israel, IIC1, 1996.
55. Moussaoui D. Biochimie de la depression. Analyse de la literature. Encephale. 4:1978;193-222.
56. 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 63:1994;617-624.
57. 2 receptors and suicide. Lancet. ii:1983;1256.
58. Owen F., Chambers D.R., Cooper S.J., Crow T.J., Johnson J.A., Lofthouse R., Poulter M. Serotonergic mechanisms in brains of suicide victims. Brain Res. 362:1986;185-188.
59. Ozawa H., Gsell W., Froellich L., Zoechling R., Pantucek F., Beckman F., Riederer P. Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients. J. Neural Transm. Gen. Sect. 94:1993;63-69.
60. Paul, S.M.; Rehavi, M.; Skolnick, P.; Goodwin, F.K. High affinity binding of anti-depressants to a biogenic amine transport site in humam brain and platelet: Studies in depression. In: Post, R.M.; Ballinger, J.C., eds. Neurobiology of Mood Disorders. Baltimore: Williams and Wilkins; 1984;845-853.
61. Perry E.K., Marshall E.F., Blessed G., Tomlinson B.E., Perry R.H. Decreased imipramine binding in the brains of patients with depressive illness. Br. J. Psychiatry. 142:1983;188-192.
62. Richelson E. Biological basis of depression and therapeutic relevance. J. Clin. Psychiat. 52(Suppl.):1991;4-10.
63. Roy, A. Suicide. In: Kaplan, H.I.; Sadock, B.J., eds. Comprehensive Textbook of Psychiatry, 6th ed. Baltimore: William & Wilkins; 1995;1739-1752.
64. Sachar E.J., Baron M. The biology of affective disorders. Annu. Rev. Neurosci. 2:1979;505-517.
65. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
66. Stanley M., Virgilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 216:1982;1337-1339.
67. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. i:1983;214-216.
68. Stockmeier C.A., Meltzer H.Y. β-Adrenergic receptor binding in frontal cortex of suicide victims. Biol. Psychiatry. 29:1991;183-191.
69. Stocks G.M., Cheetham S.C., Crompton M.R., Katona C.L.E., Horton R.W. Benzodiazepine binding sites in amygdala and hippocampus od depressed suicide victims. J. Affect. Disord. 18:1990;11-15.
70. Tsuang M.T. Suicide in schizophrenics, manics, depressives and surgical controls: A comparison with general population suicide mortality. Arch. Gen. Psychiatry. 35:1978;153-155.
71. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science. 270:1995;484-487.
72. Vetulani J. Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment. Pol. J. Pharmacol. 36:1984;101-115.
73. 2 receptor changes in major depression. Biol. Psychiatry. 27:1990;489-496.
74. Zohar, J. Is 5-HT1D involved in obsessive compulsive disorder? Abstr. Eur. Coll. Neuropsychopharmacol. 1996, p. xxx.
75. Zohar, J. Obsessive compulsive disorder - new directions. Abstracts 9th Conference Israel Psychiatric Association, 162; 1997.